Eczema Cream Recall: Dangerous Bacteria Found!

Recall warning over blurred grocery store aisle

A popular eczema cream sold on Amazon and in grocery stores nationwide has been recalled after the U.S. Food and Drug Administration (FDA) confirmed it was contaminated with a dangerous bacteria capable of causing life-threatening infections — and millions of Americans with skin conditions may have already used it.

Quick Take

Pharmacal recalled one lot of MG217 Multi-Symptom Treatment Cream after the FDA confirmed contamination with Staphylococcus aureus, the bacteria responsible for staph infections.
The affected product was distributed nationwide through Amazon, wholesale channels, and H-E-B grocery stores.
The FDA warns the contaminated cream could cause severe infections including sepsis and septic shock, particularly in people with weakened immune systems or broken skin.
No adverse events have been reported so far, but the FDA acted on a precautionary basis given the serious risk the contamination poses.

What Was Recalled and Who Is at Risk

Pharmacal issued a voluntary recall on May 8, 2026, for one specific lot of MG217 Multi-Symptom Treatment Cream and Skin Protectant Eczema Cream, conducted with the knowledge of the FDA. The recalled product is identified as lot number 1024088, with an expiration date of November 2026, product code 5106, and UPC 012277051067. Anyone who purchased this product should stop using it immediately and check the lot number on the packaging.

The FDA’s warning is especially serious for people with compromised immune systems or damaged skin — the exact population most likely to be using an eczema cream. The agency identified specific risks including skin and skin-structure infections, infective endocarditis, bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock. Eczema sufferers, by the very nature of their condition, often have broken or inflamed skin, making them particularly vulnerable to bacterial exposure from a contaminated topical product.

How the Product Reached Consumers Nationwide

The contaminated lot was distributed broadly across the country through wholesale distributors, retail grocery chains including H-E-B, and online through Amazon. The wide distribution footprint means consumers in virtually every state could have purchased the affected product without any warning. The FDA confirmed the recall is nationwide in scope, raising legitimate questions about how a product contaminated with Staphylococcus aureus cleared quality control and made it to store shelves and online storefronts in the first place.

This is precisely the kind of supply-chain and manufacturing oversight failure that demands accountability. American consumers trust that over-the-counter products — especially those designed for people with sensitive, compromised skin — meet basic safety standards before reaching their medicine cabinets. When a cream intended to soothe a painful skin condition turns out to harbor dangerous bacteria, that trust is broken. Regulators and manufacturers alike bear responsibility for ensuring this does not happen.

Precautionary Action, But Serious Contamination

As of the recall announcement, Pharmacal reported no adverse events linked to the contaminated lot, and the FDA has not cited any documented injuries. However, the absence of reported harm does not diminish the seriousness of the contamination finding. FDA policy on topical product recalls is risk-based, not injury-based — meaning regulators act when a credible contamination threat is confirmed, before people get hurt. That is the system working as it should, and consumers should take the warning seriously regardless of the current absence of reported cases.

MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream by Pharmacal: Recall – Due to Microbial Contamination https://t.co/FGulpFosCO pic.twitter.com/wkW1qA6oTv

— US FDA MedWatch (@FDAMedWatch) May 13, 2026

If you purchased MG217 Multi-Symptom Treatment Cream recently, check the lot number on the packaging against the recalled lot 1024088. Stop using the product immediately if it matches. The FDA advises consumers to contact their physician or healthcare provider if they have experienced any health problems that may be related to using this product. Consumers with questions can contact Pharmacal directly. The FDA’s full safety alert is publicly available and provides complete product identification details for verification.